Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1973 2
1975 5
1976 1
1978 4
1979 1
1980 1
1982 2
1983 3
1984 3
1985 3
1986 3
1987 6
1988 7
1989 4
1990 8
1991 10
1992 8
1993 10
1994 11
1995 9
1996 6
1997 17
1998 12
1999 10
2000 15
2001 15
2002 12
2003 20
2004 20
2005 22
2006 20
2007 22
2008 29
2009 16
2010 18
2011 31
2012 23
2013 28
2014 31
2015 34
2016 22
2017 22
2018 24
2019 22
2020 21
2021 20
2022 26
2023 22
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

625 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Localized Parathyroid Gland Carcinoma"
Page 1
Parathyroid Imaging.
Itani M, Middleton WD. Itani M, et al. Radiol Clin North Am. 2020 Nov;58(6):1071-1083. doi: 10.1016/j.rcl.2020.07.006. Epub 2020 Sep 17. Radiol Clin North Am. 2020. PMID: 33040849 Review.
Primary hyperparathyroidism (PHPT) is a common endocrine abnormality, caused in most cases by a single parathyroid adenoma. Surgery remains the first-line curative therapy in PHPT. Imaging plays a vital role in presurgical localization of parathyroid adenomas …
Primary hyperparathyroidism (PHPT) is a common endocrine abnormality, caused in most cases by a single parathyroid adenoma. Surgery r …
Parathyroid carcinoma: molecular therapeutic targets.
Marini F, Giusti F, Palmini G, Aurilia C, Donati S, Brandi ML. Marini F, et al. Endocrine. 2023 Sep;81(3):409-418. doi: 10.1007/s12020-023-03376-w. Epub 2023 May 9. Endocrine. 2023. PMID: 37160841 Review.
Parathyroid carcinoma (PC) is an extremely rare malignant tumor of the parathyroid glands, accounting for less than 1% of primary hyperparathyroidism, commonly characterized by severe and unmanageable hypercalcemia, aggressive behavior, high metastatic potent …
Parathyroid carcinoma (PC) is an extremely rare malignant tumor of the parathyroid glands, accounting for less than 1% …
Parathyroid carcinoma.
Givi B, Shah JP. Givi B, et al. Clin Oncol (R Coll Radiol). 2010 Aug;22(6):498-507. doi: 10.1016/j.clon.2010.04.007. Epub 2010 May 26. Clin Oncol (R Coll Radiol). 2010. PMID: 20510594 Free PMC article. Review.
Parathyroid carcinoma is a rare endocrine malignancy. The reported incidence is from 0.5 to 5% of primary hyperparathyroidism cases in various series. ...Most patients will present with signs and symptoms of hypercalcaemia. Cases of non-functioning carcinoma …
Parathyroid carcinoma is a rare endocrine malignancy. The reported incidence is from 0.5 to 5% of primary hyperparathyroidism …
Parathyroid carcinoma.
Kebebew E. Kebebew E. Curr Treat Options Oncol. 2001 Aug;2(4):347-54. doi: 10.1007/s11864-001-0028-2. Curr Treat Options Oncol. 2001. PMID: 12057115 Review.
Although parathyroid neoplasms are common and cause primary hyperparathyroidism, parathyroid carcinoma is a rare entity. ...Patients who have persistent or recurrent parathyroid carcinoma should have localizing studies to identify …
Although parathyroid neoplasms are common and cause primary hyperparathyroidism, parathyroid carcinoma is a rare …
Parathyroid cancer: An update.
Rodrigo JP, Hernandez-Prera JC, Randolph GW, Zafereo ME, Hartl DM, Silver CE, Suárez C, Owen RP, Bradford CR, Mäkitie AA, Shaha AR, Bishop JA, Rinaldo A, Ferlito A. Rodrigo JP, et al. Cancer Treat Rev. 2020 Jun;86:102012. doi: 10.1016/j.ctrv.2020.102012. Epub 2020 Mar 19. Cancer Treat Rev. 2020. PMID: 32247225 Review.
Parathyroid cancer (PC) is a rare malignant tumor which comprises 0.5-5% of patients with primary hyperparathyroidism (PHPT). ...Although PC is characterized by high levels of serum ionized calcium (Ca) and parathyroid hormone (PTH), the challenge to the clinician i …
Parathyroid cancer (PC) is a rare malignant tumor which comprises 0.5-5% of patients with primary hyperparathyroidism (PHPT). ...Alth …
Parathyroid Carcinoma: Diagnosis and Clinical Implications.
Duan K, Mete Ö. Duan K, et al. Turk Patoloji Derg. 2015;31 Suppl 1:80-97. doi: 10.5146/tjpath.2015.01316. Turk Patoloji Derg. 2015. PMID: 26177319 Free article. Review.
Parathyroid carcinoma is a rare type of endocrine cancer, with significant morbidity and mortality associated with parathyroid hormone (PTH)-mediated hypercalcemia. ...Recent advances in molecular pathology have uncovered the important role of CDC73/HRPT2, a …
Parathyroid carcinoma is a rare type of endocrine cancer, with significant morbidity and mortality associated with parathyr …
Update on parathyroid carcinoma.
Cetani F, Pardi E, Marcocci C. Cetani F, et al. J Endocrinol Invest. 2016 Jun;39(6):595-606. doi: 10.1007/s40618-016-0447-3. Epub 2016 Mar 21. J Endocrinol Invest. 2016. PMID: 27001435 Review.
INTRODUCTION: Parathyroid carcinoma (PC) is a rare endocrine disorder, commonly causing severe primary hyperparathyroidism (PHPT). ...CONCLUSIONS: The treatment of choice is the en bloc resection of the tumor. The course of PC is variable; most patients have …
INTRODUCTION: Parathyroid carcinoma (PC) is a rare endocrine disorder, commonly causing severe primary hyperparathyroidism (PH …
Parathyroid carcinoma: etiology, diagnosis, and treatment.
Okamoto T, Iihara M, Obara T, Tsukada T. Okamoto T, et al. World J Surg. 2009 Nov;33(11):2343-54. doi: 10.1007/s00268-009-9999-0. World J Surg. 2009. PMID: 19350316 Review.
BACKGROUND: The goal of the present study was to make our medical practice evidence-based for patients with parathyroid carcinoma. METHODS: We posed six clinical questions relevant to the management of parathyroid cancer. ...Severe hypercalcemia and its relat …
BACKGROUND: The goal of the present study was to make our medical practice evidence-based for patients with parathyroid carcinoma …
Neoplastic metastases to the endocrine glands.
Angelousi A, Alexandraki KI, Kyriakopoulos G, Tsoli M, Thomas D, Kaltsas G, Grossman A. Angelousi A, et al. Endocr Relat Cancer. 2020 Jan;27(1):R1-R20. doi: 10.1530/ERC-19-0263. Endocr Relat Cancer. 2020. PMID: 31645015 Review.
Pancreatic metastasis can lead to exo-/endocrine insufficiency with renal carcinoma being the most common primary. Most parathyroid metastases originate from breast and lung carcinomas and melanoma. ...As most metastases to endocrine organs develop in the context of …
Pancreatic metastasis can lead to exo-/endocrine insufficiency with renal carcinoma being the most common primary. Most parathyroi …
Parathyroid cancer: A systematic review of diagnostic biomarkers.
Davies MP, John Evans TW, Tahir F, Balasubramanian SP. Davies MP, et al. Surgeon. 2021 Dec;19(6):e536-e548. doi: 10.1016/j.surge.2021.01.011. Epub 2021 Feb 26. Surgeon. 2021. PMID: 33642204 Review.
INTRODUCTION: Parathyroid cancers are rare and difficult to distinguish from benign parathyroid tumours. ...Standard histology is also inadequate; especially in the absence of local invasion, lymph nodal disease and metastasis. The aim of this project was to …
INTRODUCTION: Parathyroid cancers are rare and difficult to distinguish from benign parathyroid tumours. ...Standard histology …
625 results